Program
Preliminary program
<<< Download >>>
Wednesday 15th November - 3 parallel workshops:
Parallel sessions organized by Axis 2 - Genome Dynamics and cancer
- 14:00 - 16:00 : Cell cycle and cancer
Chairs: Malik LUTZMANN, Martin TEICHMANN
- KEYNOTE SPEAKER: Daniele FACHINETTI, Curie Institute (Paris) - Lecture: Revealing the consequences of human centromere dysfunction
- Anna CASTRO, Montpellier Cell Biology Research Center (Montpellier) - A new pathway controlling DNA replication in human cells
- Derek McCUSKER, Biochemistry and Cellular Genetics Institute & IECB (Bordeaux) - Self-organization during cell cycle-dependent polarity axis establishment
- Dorian LARRIEU, Cancer Research Center of Toulouse (Toulouse) - A new role for the E3 ubiquitin ligase TRIP12 in mitosis and genomic stability in human pancreatic cancer
- Jean-Paul JAVERZAT, Biochemistry and Cellular Genetics Institute (Bordeaux) - A novel mode of sister chromatid cohesion controlled by cohesin phosphorylation
- 16:30 - 18:30 : Chromatin dynamics and cancer
Chairs: Kerstin BYSTRICKY, Stefania MILLEVOI
- KEYNOTE SPEAKER: Sophie POLO, Epigenetics and Cell Fate Center (Paris) - Lecture: Epigenome maintenance in response to DNA damage
- Jean-Christophe ANDRAU, Institute of Molecular Genetics of Montpellier (Montpellier) - Transcription termination and genome organisation
- Kerstin BYSTRICKY, Laboratory of Eukaryotic Molecular Biology / Integrative Biology Center (Toulouse) - Quantitative analysis of chromatin complexes dynamics at sub-diffraction resolution during transcription
- Jérémie RISPAL, Laboratory of Eukaryotic Molecular Biology / Integrative Biology Center (Toulouse) - An epistatic relationship between CDX2 and histone variant H2A.Z controls the intestinal epithelial cell fate
- Eric PINAUD, Control of B Immune Response and Lymphoproliferations (Limoges) - Implication of Nuclear Matrix Attachment Regions and their binding proteins in targeting AID-driven "off target" mutations
Parallel sessions organized by Axis 3 - Translational Research, from Biology to Clinical Research and Axis 5 - Health technologies
- 14:00 - 16:00 : Therapeutic targeting, tumor vectorization
Chairs: Véronique GIGOUX, Vincent SOL
- KEYNOTE SPEAKER: Gert STORM, Utrecht University (Netherlands) - Lecture : Targeted particulate nanomedicines in oncology: current status and way forward
- Sébastien PAPOT, Institute of Chemistry: Mediums and Natural Resources (Poitiers) - From Molecular Programming to the Selective Delivery of Anticancer Drugs
- Christophe GROSSET, Biotherapy for getetic diseases, inflammation and cancer (Bordeaux) - New insights into diagnosis and therapeutic options for proliferative hepatoblastoma
- Audrey FRANCES, Cancer Research Center of Toulouse (Toulouse) - Exploring a new function for cytidine deaminase in pancreatic cancer metabolism
- François GUILHOT, University Hospital (Poitiers) - Cytogenetic, molecular responses and survival improvement in chronic myeloid leukemia patients in chronic phase over a 20 years period of research
- 16:30 - 18:30 : Therapeutic targeting, tumor vectorization and radiotherapy
Chairs: Carmen LLACER, Guy KANTOR
- KEYNOTE SPEAKER: Elif HINDIE, University Hospital (Bordeaux) - Lecture: The theranostic "Image and Treat" approach in nuclear medicine
- Mikaela DIMITRIU, Nanobiotix (Paris) - Hafnium oxide nanoparticles as an emergent promising treatment for solid tumors
- Camille VERRY, University Hospital (Grenoble) - Phase I clinical trial for radiosensitization of multiple brain metastases with AGuIX nanoparticles: preliminary results
- Alexandre PICHARD, Cancer Research Institute of Montpellier (Montpellier) - 177Lu-lilotomab is more efficient than rituximab in the therapy of non-Hodgkin B lymphoma cells showing reduced Wee1-mediated phosphorylation of CDK1
- Aya ABOU HAMMOUD, Bordeaux Research in Translational Oncology (Bordeaux) - Discoidin Domain Receptor 2 (DDR2) involvement in matrix degradation in a tumor neo-angiogenesis context
Thursday 16th November - Plenary sesssions dedicated to tumor heterogeneity:
- 8:30 - 10:30 : The different sides of tumor heterogeneity
Chairs: Karine DUDAND, Daniel FISHER
- KEYNOTE SPEAKER
- Frédéric CHIBON, Cancer Research Center of Toulouse (Toulouse) - Beyond the genetic intra-tumoral heterogeneity of Sarcomas
- Guillaume BELTHIER, Institute for Functional Genomics (Montpellier) - A new promising marker for CTCs with CSC properties ?
- Margaux SALA, Bordeaux Research in Translational Oncology (Bordeaux) - Involvement of discoidin domain receptor 1 and 2 in resistance during melanoma
- Andréï TURTOI, Institute of Cancer Research of Montpellier (Montpellier) - Cancer-Assciated Fibroblasts: Tumor Allies and Foes
- 11:00 - 12:30 : Single Cell technology
Chairs: Anne-Marie GUE, Eric JULIEN
- KEYNOTE SPEAKER: Chris BAKAL, Institute of Cancer Research (London, UK) - Lecture: Using image-omics to understand how changes in cell shape drive cancer
- Olivier CUVIER, Center for Integrative Biology (Toulouse) - Chromatin-encoded transcriptional memory : novel insights from single-cell omics
- Françoise ARGOUL, Waves and Matter Laboratory of Aquitaine (Bordeaux) and Physics Laboratory (Lyon) - Prodding single leukemia cells with nanoprobes provides cancer clues
- Jean-Jacques FOURNIE, Cancer Research Center of Toulouse (Toulouse) - What to expect from scRNASeq analyses ?
- 14:30 - 16:00 : Precision medicine: to go where ? (1)
Chairs: Gilles FAVRE, David TOUGERON
- KEYNOTE SPEAKER: Patrick MEHLEN, Cancer research Centre of Lyon (Lyon) - Lecture: Targeting dependence receptors: from a cell biology paradigm to clinical trial
- Catherine CHEZE LE REST, University Hospital (Poitiers) - Multiparametric and multimodality imaging for prognostic and predictive modeling in oncology
- Jean-Philippe MERLIO, Bordeaux Research in Translational Oncology / University Hospital (Bordeaux) - The expression pattern of PD-L1 and PD-L2 in diffuse large B-cell lymphoma, leg type underscores pitfalls of routine immunohistochemical assessment
- Camille EVRARD, University Hospital (Poitiers) - KRASCIPANC: Pronostic and predictive value of circulating DNA in unressectable pancreatic adenocarcinoma
- 16:30 - 18:30 : Precision medicine: to go where ? (2)
Chairs: Gilles FAVRE, Philippe GORRY
- KEYNOTE SPEAKER: Fabrice ANDRE, Institut Gustave Roussy (Paris) - Lecture
- KEYNOTE SPEAKER: Sophie DAY, Imperial College (London) - Lecture
- KEYNOTE SPEAKER: Isabelle DURAND-ZALESKI, Assistance Publique - Hôpitaux de Paris (Paris) - Lecture
- Round table
Friday 17th November - 2 parallel workshops and plenary session:
Parallel session organized by Axis 1 - Cell Signaling and Therapeutic Targets
- 8:30 - 10:15 : Tumor niche and microenvironment
Chairs: Bruno CONSTANTIN, Julie PANNEQUIN
- KEYNOTE SPEAKER: Simone P. NICLOU, Luxembourg Institute of Health (Luxembourg) - Lecture: Tumour-host interactions in Glioblastoma
- Catherine MULLER, Institute of Pharmacology and Structural Biology (Toulouse) - Dissemination of prostate cancer : a way paved of fat
- Christos PETROPOULOS, University Hospital / Clinical and Experimental Neurosciences Laboratory (Poitiers) - Functional invadopodia formed in glioblastoma stem cells drive tumor angiogenesis
- Nicolas LARMONIER, Immunology from Concept and Experiments to Translation (Bordeaux) - T helper 9 lymphocytes in cancer
- Marie SIMONNEAU, Inflammation, Epithelial Tissus and Cytokines Laboratory (Poitiers) - Oncostatin M promotes tumor progression in skin squamous-cell carcinoma
Parallel session organized by Axis 5 - Health technologies
- 8:30 - 10:15 : High-resolution imaging & Cancer
Chairs: Laurent COGNET, Vincent COUDERC
- KEYNOTE SPEAKER: Gerhard SCHUTZ, Technical University (Vienna) - Lecture: The enigmatic role of lipids for membrane protein interaction: a microscopist's point of view
- Philippe LEPROUX, XLim (Limoges) - Multimodal imaging under supercontinuum illumination and electric field stimulation
- Pierre BON, Institut Optique Graduate School (Bordeaux) - Quantitative Phase Imaging, from white light imaging to fluorescence super-resolution
- Haitham SHABAN, Laboratory of Eukaryotic Molecular Biology / Integrative Biology Center (Toulouse) - Quantitative analysis of chromatin complexes dynamics at sub-diffraction resolution during transcription
- Laurent COGNET, Institut Optique / Photonics, Numeric and Nanosciences Laboratory (Talence) - Quantitative optical microscopy of infrared nano-markers for cancer tissue characterization
Plenary session
- 10:45 - 12:15 : Metastatic disease
Chairs: Gilles FAVRE, Julie PANNEQUIN
- KEYNOTE SPEAKER : Giorgio STASSI, University of Palermo (Palermo) - Lecture: PI3K-driven survival of colorectal cancer stem cells is overcame by MAPK inhibition
- Serge ROCHE, Montpellier Cell Biology Research Center (Montpellier) - Metastatic activity of the receptor tyrosine kinase for collagens DDR1 in colorectal cancer
Mercredi 15 et Jeudi 16 Novembre, sessions parallèles organisées par l'Axe 4 - Cancer, enjeux individuels et collectifs
Mercredi 15 Novembre
- 14:00 - 16:00 : Dépistage
Modération: Annie SASCO
- ORATEUR INVITE: Andréas ULLRICH, Organisation mondiale de la santé (Genève) - Conférence: Les enjeux du dépistage
- Caroline Tournoux FACON & Isabelle INGRAND, Structure de gestion des dépistages organisées des cancers dans la Vienne et Unité de biostatistique et d'épidémiologie (Poitiers) - Rôle des professionnels de santé dans l’information donnée aux femmes dans le cadre du dépistage
- Isabelle INGRAND & Ludovic GAUSSOT, Unité de biostatistique et d'épidémiologie et GRESCO (Poitiers) - Regards croisés sur l'efficacité d'une intervention personnalisée dans le dépistage ciblé du cancer colorectal. Etude Color2
- Marie POISEUIL - Registre général des cancers de la Gironde (Bordeaux) - Rôle des inégalités sociodémographiques sur la survie des femmes ayant un cancer du sein selon leur participation au dépistage
- 16:30 - 18:00 : Relation médecin - malade et Prise en charge (1)
Modération: Dolores ALBARRACIN
- ORATEUR INVITE: Christine REYNAERT, Université Catholique de Louvain (Louvain) - Conférence: "Je t'écoute... moi non plus" à propos de la communication médecin patient
- Stéphane JOUFFRE et Dolorès ALBARRACIN, CERCA et CAPS (Poitiers) - Ethiques et soins palliatifs: la perception des médecins du dispositif des directives anticipées écrites par leurs patients.
- Isabelle INGRAND et Estelle LAURENT, INSERM CIC 1402 CHU de Poitiers et GRESCO (Poitiers) - Analyse de la relation médecin/patient/proche dans le cadre de l'annonce d'une "mauvaise nouvelle" en oncologie - étude BABEL.
- Sarah HABIB-HADEF, ONCODEFI (Montpellier) - Obstacles aux soins et à la prise en charge du cancer des personnes déficientes intellectuelles.
Jeudi 16 Novembre
- 11:00 - 12:30 : Relation médecin - malade et prise en charge (2)
Modération: Dolores Albaraccin
- ORATEUR INVITE: Raphaël HAMMER, HESAV (Lausanne) - Conférence: Entre enjeux théoriques et transformations sociétales: la confiance dans la relation médecin-patient
- Annick TIJOU-TRAORE, Les Afriques dans le Monde (Bordeaux) - Choisir et vivre son traitement contre le cancer quand on est âgé et polypathologique
- Anita MEIDANI & Arnaud ALESSANDRIN, LISST & Centre Emile Durkheim (Toulouse, Bordeaux) - La relation soignant·e·s / soigné·e·s au prisme du genre
- 14:30 - 16:00 : Chronicité et guérison
Modérarion: Béatrice Jacques
- ORATEUR INVITE: Angélique BONNAUD-ANTIGNAC, Institut de Cancérologie de L'Ouest & Inserm (Nantes) - Conférence: Le cancer: une maladie chronique? Ou l'impossible guérison
- Ludovic GAUSSOT, GRESCO (Poitiers) - L’expérience de la maladie chronique - éducation thérapeutique, insertion, socialisation
- David SAINT MARC, Centre Emile Durkheim (Bordeaux) - Autonomie et chronicité
